title: Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.
authors.forename: A
authors.initials: A
authors.lastname: Pia
authors.forename: A
authors.initials: A
authors.lastname: Berruti
authors.forename: M
authors.initials: M
authors.lastname: Terzolo
authors.forename: P
authors.initials: P
authors.lastname: Paccotti
authors.forename: C
authors.initials: C
authors.lastname: Letizia
authors.forename: L
authors.initials: L
authors.lastname: Dogliotti
authors.forename: A
authors.initials: A
authors.lastname: Angeli
mesh_terms: D000293:Adolescent; D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D005047:Etoposide; D008939:Mitotane; D004317:Doxorubicin; D002945:Cisplatin